Short answer · Medically reviewed summary · Last updated: 2026-05-08
Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder historically referred to by several names including Shy-Drager syndrome and Parkinson’s Plus disease. While these terms appear in older literature or specific clinical contexts, Multiple System Atrophy is the currently accepted medical term used to encompass the various clinical presentations of this condition. Why does Multiple System Atrophy have multiple names? The naming of Multiple System Atrophy has evolved as medical understanding of the disease has deepened.
2 people with Multiple Systems Atrophy have shared their first-person experience on this question at DiseaseMaps.
Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder historically referred to by several names including Shy-Drager syndrome and Parkinson’s Plus disease. While these terms appear in older literature or specific clinical contexts, Multiple System Atrophy is the currently accepted medical term used to encompass the various clinical presentations of this condition.
The naming of Multiple System Atrophy has evolved as medical understanding of the disease has deepened. Historically, patients were categorized by their most prominent symptoms; for instance, cases with severe autonomic failure were often called Shy-Drager syndrome, while those presenting with parkinsonism were labeled as Parkinson’s Plus. As research confirmed these were all manifestations of the same underlying pathology—the accumulation of alpha-synuclein protein in the brain—the medical community consolidated these under the umbrella of Multiple System Atrophy to improve diagnostic consistency and research collaboration.
You may encounter various terms in medical records or legacy research papers depending on when or where the diagnosis was made. Common synonyms and historical designations include:
Standardized medical classifications now use Multiple System Atrophy to ensure global consistency. In the Orphanet database, it is listed as ORPHA:590, and in the OMIM database, it is cataloged under entries related to the alpha-synucleinopathies. Using the term Multiple System Atrophy when communicating with healthcare providers helps ensure you are accessing the most current clinical guidelines and research data.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.